Transformation of Prostate Adenocarcinoma Into Small-Cell Neuroendocrine Cancer Under Androgen Deprivation Therapy: Much Is Achieved But More Information Is Needed

J Clin Oncol. 2019 Feb 1;37(4):350-351. doi: 10.1200/JCO.18.01055. Epub 2018 Dec 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma*
  • Androgen Antagonists
  • Carcinoma, Neuroendocrine*
  • Genomics
  • Humans
  • Male
  • Prospective Studies
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists